BiochemProbe — Life Science Research Reagents

S-600918 free base · Synonyms: Sivopixant

Sivopixant is a potent and selective P2X3 receptor antagonist.

For research use only. Not for human or veterinary use.

Target P2X Receptor
Research area Neurological Disease
Purity >98% Stock Inquire

S-600918 structure

CAS No.: 2414285-40-6

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
25 mg USD 360.00 BP-02009-25mg In stock Get quote
50 mg USD 512.00 BP-02009-50mg In stock Get quote
100 mg USD 708.00 BP-02009-100mg In stock Get quote
250 mg USD 1,132.00 BP-02009-250mg In stock Get quote
500 mg USD 1,580.00 BP-02009-500mg In stock Get quote
1 g Inquire BP-02009-1g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

Sivopixant (S-600918) is a potent and selective P2X3 receptor antagonist (P2X3 IC50=4.2 nM; P2X2/3 IC50=1100 nM). Sivopixant shows strong analgesic effect.

Biological activity

In Vivo Sivopixant (S-600918) (i.v.;1 mg/kg) shows a longer half-life (T1/2= 10.1 hours) and a strong analgesic effect in the rat Seltzer model of allodynia (ED50=0.4 mg/kg).

Identifiers

SMILES
O=C([C@H](CN1C(N(/C(NC1=O)=N/C2=CC=C(C=C2)OC3=NC=CC=C3)CC4=CC=C(C=C4)Cl)=O)C)O
InChIKey
SKZQFKBIJUXXCG-INIZCTEOSA-N

Specifications

MW (average)
507.9260
Formula
C25H22ClN5O5
CAS No.
2414285-40-6
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO 12.5 mg/mL

References

[1]. Kai H, et al. Discovery of clinical candidate Sivopixant (S-600918): Lead optimization of dioxotriazine derivatives as selective P2X3 receptor antagonists [published online ahead of print, 2021 Sep 26]. Bioorg Med Chem Lett. 2021;52:128384.

Same target

Search P2X Receptor

Same research area

Search Neurological Disease